SCHEMBL14255187

SCHEMBL14255187

COC(=O)c1cc2ccccc2c(=O)c2ncccc12

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.57
▸ ALDH1A1 P00352 4/20 0.51
▸ HPGD P15428 3/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ PSMD14 O00487 1/20 0.48
▸ MAP2K1 Q02750 1/20 0.48
▸ SLC40A1 Q9NP59 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ ALOX15 P16050 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.44
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ PTPN1 P18031 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14255189 0.89 KDM4E (0.53) KDM4EALDH1A1HPGDNPSR1PSMD14
SCHEMBL9945608 0.85 KDM4E (0.57) KDM4EALDH1A1HPGDNPSR1PSMD14
SCHEMBL14255197 0.83 KDM4E (0.48) KDM4EALDH1A1HPGDNPSR1PSMD14
SCHEMBL14255204 0.82 KDM4E (0.47) KDM4EALDH1A1HPGDNPSR1PSMD14
SCHEMBL14255505 0.79 CHEK1 (0.49) KDM4EALDH1A1MAP2K1SLC40A1MEN1
SCHEMBL14255190 0.78 MEN1 (0.45) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL1539120 0.76 ALDH1A1 (0.66) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL23212200 0.76 KDM4E (0.57) KDM4EALDH1A1HPGDNPSR1PSMD14
SCHEMBL23233761 0.74 KDM4E (0.70) KDM4EALDH1A1PSMD14MAP2K1SLC40A1
SCHEMBL14255198 0.74 KDM4E (0.45) KDM4EALDH1A1HPGDNPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342016-B2 Farnesyl protein transferase inhibitors as antitumor agents SCHERING CORPORATION (US) 2008-03-11 — — US disclosed
US-7342016-B2 Farnesyl protein transferase inhibitors as antitumor agents SCHERING CORPORATION (US) 2008-03-11 — — US disclosed
EP-1313725-B1 TRICYCLIC ANTITUMOR COMPOUNDS BEING FARNESYL PROTEIN TRANSFERASE INHIBITORS SCHERING CORP (US) 2007-04-11 — — EP disclosed
Send feedback